ABOUT
Keeping pace with the speed of science:
The life sciences landscape is evolving faster than ever. Our client, a leader in biomarker discovery, development, and commercialisation, needed a campaign that could demonstrate how precision medicine outmanoeuvres the relentless progress of disease while reinforcing their reputation for innovation, trust, and quality.
A metaphor built on strategy:
We turned to chess - a universal language of foresight and adaptability. Each bespoke piece represented a stage in the biomarker journey, inviting partners to choose their own starting point.
In contrast, tumour-inspired pieces embodied the unpredictability of disease: aggressive, adaptive, and always on the move.
Science as strategy, design as storytelling:
By framing biomarker science as a battle of moves and countermoves, we highlighted the critical role of precision medicine in anticipating, adapting, and overcoming disease. The metaphor elevated the science into a narrative of human impact—where innovation is not just technical, but transformative.
A campaign with scientific precision:
Launched in 2022, the full campaign captured the imagination of audiences worldwide. The campaign became a powerful expression of our client’s competitive advantage: flexible, innovative, trusted, and always advancing the future of human health.
MADEIT CREDITS
-

Diagnostic ServicesClient
-

The Mission Control Communications -

Laurence ReaAssociate Director -

EmerBrand Designer -

MartinAnimator -

James KilloranHead of Strategy

Back to Anticipating disease. Accelerating discovery. Advancing health. project